Intra-Cellular Therapies revenue

Intra-Cellular Therapies revenue decreased from $245.8 thousand in 2017 to $0 in 2018, a 100% decrease.

Annual Revenue ($)

Intra-Cellular Therapies revenue was $245.84 k in FY, 2017

Quarterly Revenue ($)

FY, 2013FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017
Revenue$2.74 m$2.74 m$577.30 k$91.36 k$330.70 k$245.84 k
Growth(78.91%)(84.17%)261.96%
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017
Revenue$667.96 k$167.79 k$219.24 k$124.41 k$3.32 k$57.39 k$124.41 k$3.32 k$228.45 k$4.36 k$95.29 k$114.74 k$30.75 k

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue

FY, 2014FY, 2015
License and collaboration revenue547.55 k30.66 k
Grant Revenue29.76 k60.71 k